Literature DB >> 27878658

Role of Matricellular Proteins in Disorders of the Central Nervous System.

A R Jayakumar1, A Apeksha1,2, M D Norenberg3,4,5,6.   

Abstract

Matricellular proteins (MCPs) are actively expressed non-structural proteins present in the extracellular matrix, which rapidly turnover and possess regulatory roles, as well as mediate cell-cell interactions. MCPs characteristically contain binding sites for other extracellular proteins, cell surface receptors, growth factors, cytokines and proteases, that provide structural support for surrounding cells. MCPs are present in most organs, including brain, and play a major role in cell-cell interactions and tissue repair. Among the MCPs found in brain include thrombospondin-1/2, secreted protein acidic and rich in cysteine family (SPARC), including Hevin/SC1, Tenascin C and CYR61/Connective Tissue Growth Factor/Nov family of proteins, glypicans, galectins, plasminogen activator inhibitor (PAI-1), autotaxin, fibulin and perisostin. This review summarizes the potential role of MCPs in the pathogenesis of major neurological disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, ischemia, trauma, hepatic encephalopathy, Down's syndrome, autism, multiple sclerosis, brain neoplasms, Parkinson's disease and epilepsy. Potential therapeutic opportunities of MCP's for these disorders are also considered in this review.

Entities:  

Keywords:  Astrocytes; Cell–cell interaction; Matricellular proteins; Neurological disorders

Mesh:

Substances:

Year:  2016        PMID: 27878658     DOI: 10.1007/s11064-016-2088-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  227 in total

Review 1.  Tenascin-R as a regulator of CNS glial cell function.

Authors:  P Pesheva; S Gloor; R Probstmeier
Journal:  Prog Brain Res       Date:  2001       Impact factor: 2.453

2.  The extracellular matrix molecule tenascin C modulates expression levels and territories of key patterning genes during spinal cord astrocyte specification.

Authors:  Michael Karus; Bernd Denecke; Charles ffrench-Constant; Stefan Wiese; Andreas Faissner
Journal:  Development       Date:  2011-11-09       Impact factor: 6.868

3.  Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.

Authors:  Q Shi; S Bao; L Song; Q Wu; D D Bigner; A B Hjelmeland; J N Rich
Journal:  Oncogene       Date:  2007-01-08       Impact factor: 9.867

4.  Overexpression of Fibulin-5 Attenuates Ischemia/Reperfusion Injury After Middle Cerebral Artery Occlusion in Rats.

Authors:  Jia Guo; Chuang Cheng; Cindy Si Chen; Xiangfeng Xing; Guanghui Xu; Jinzhou Feng; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2015-05-30       Impact factor: 5.590

5.  Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1.

Authors:  V Pijuan-Thompson; J R Grammer; J Stewart; R L Silverstein; S F Pearce; G P Tuszynski; J E Murphy-Ullrich; C L Gladson
Journal:  Exp Cell Res       Date:  1999-05-25       Impact factor: 3.905

6.  Thrombospondin 2 regulates cell proliferation induced by Rac1 redox-dependent signaling.

Authors:  Neuza Lopes; David Gregg; Sanjay Vasudevan; Hamdy Hassanain; Pascal Goldschmidt-Clermont; Hervé Kovacic
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

7.  Long and short splice variants of human tenascin differentially regulate neurite outgrowth.

Authors:  S Meiners; H M Geller
Journal:  Mol Cell Neurosci       Date:  1997       Impact factor: 4.314

Review 8.  Tenascins.

Authors:  Ruth Chiquet-Ehrismann
Journal:  Int J Biochem Cell Biol       Date:  2004-06       Impact factor: 5.085

9.  Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion.

Authors:  Teng-nan Lin; Gyoeng-Moon Kim; Jean-Ju Chen; Wai-Mui Cheung; Yong Y He; Chung Y Hsu
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

10.  SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion.

Authors:  Christopher K Yunker; William Golembieski; Nancy Lemke; Chad R Schultz; Simona Cazacu; Chaya Brodie; Sandra A Rempel
Journal:  Int J Cancer       Date:  2008-06-15       Impact factor: 7.396

View more
  15 in total

Review 1.  Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Histol Histopathol       Date:  2020-02-06       Impact factor: 2.303

Review 2.  Extracellular Matrix in Neural Plasticity and Regeneration.

Authors:  Yurii A Chelyshev; Ilyas M Kabdesh; Yana O Mukhamedshina
Journal:  Cell Mol Neurobiol       Date:  2020-10-31       Impact factor: 5.046

Review 3.  Cellular and Molecular Regulation of Exercise-A Neuronal Perspective.

Authors:  Ishitha Reddy; Yamini Yadav; Chinmoy Sankar Dey
Journal:  Cell Mol Neurobiol       Date:  2022-08-20       Impact factor: 4.231

4.  DNA methylation-based surrogates of plasma proteins are associated with Parkinson's disease risk.

Authors:  Katherine A Fu; Kimberly C Paul; Ake T Lu; Steve Horvath; Adrienne M Keener; Yvette Bordelon; Jeff M Bronstein; Beate Ritz
Journal:  J Neurol Sci       Date:  2021-11-03       Impact factor: 4.553

5.  Roles of the synaptic molecules Hevin and SPARC in mouse neuromuscular junction development and repair.

Authors:  Vanessa L Brayman; Thomas Taetzsch; MacKenzie Miko; Shreyaska Dahal; W Christopher Risher; Gregorio Valdez
Journal:  Neurosci Lett       Date:  2021-01-22       Impact factor: 3.046

6.  SPARC and GluA1-Containing AMPA Receptors Promote Neuronal Health Following CNS Injury.

Authors:  Emma V Jones; Yann Bernardinelli; Juan G Zarruk; Sabrina Chierzi; Keith K Murai
Journal:  Front Cell Neurosci       Date:  2018-02-01       Impact factor: 5.505

7.  Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway.

Authors:  Huixia Lu; Xunian Zhou; Hoi-Hin Kwok; Mei Dong; Zhaoqiang Liu; Po-Ying Poon; Xiaorong Luan; Ricky Ngok-Shun Wong
Journal:  Front Pharmacol       Date:  2017-11-13       Impact factor: 5.810

8.  Association of accelerated long-term forgetting and senescence-related blood-borne factors in asymptomatic individuals from families with autosomal dominant Alzheimer's disease.

Authors:  Jianwei Yang; Chaojun Kong; Longfei Jia; Tingting Li; Meina Quan; Yan Li; Diyang Lyu; Fangyu Li; Hongmei Jin; Ying Li; Qigeng Wang; Jianping Jia
Journal:  Alzheimers Res Ther       Date:  2021-05-27       Impact factor: 6.982

Review 9.  Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?

Authors:  Marzena Wyganowska-Świątkowska; Maja Matthews-Kozanecka; Teresa Matthews-Brzozowska; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Int J Mol Sci       Date:  2018-01-15       Impact factor: 5.923

10.  Meta-analysis of mouse transcriptomic studies supports a context-dependent astrocyte reaction in acute CNS injury versus neurodegeneration.

Authors:  Sudeshna Das; Zhaozhi Li; Ayush Noori; Bradley T Hyman; Alberto Serrano-Pozo
Journal:  J Neuroinflammation       Date:  2020-07-31       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.